Press releases
Read more:
Categories
2021
2021-04-21 09:54
Nanologica Announces Date Change for Annual Report
Financial calendar 2021 Interim report January-March 2021 April 23, 2021 Annual Report 2020...
2021-04-13 08:38
Nanologica’s Nomination Committee Proposes Thomas Eldered as New Board Member of Nanologica AB
Thomas Eldered holds a M.Sc. in Industrial and Management Engineering from Linköping Institute of Technology and is the co-founder of Recipharm AB...
2021-04-13 08:00
Nanologica’s Nomination Committee Proposes Thomas Eldered as New Board Member of Nanologica AB
Thomas Eldered, who recently left his position as CEO of Recipharm and who is Nanologica’s largest shareholder, is proposed as new member of the...
In addition, the date for the interim report for the second quarter 2021 has been changed from August 27, 2021 to July 9, 2021. Financial calendar 2021...
Nanologica’s drug delivery platforms NLAB Spiro® and NLAB Silica™ consists of nanoporous particles where APIs can be placed inside the...
2021-02-26 08:20
Year-End Report Nanologica 2020
STRONG PERFORMANCE AND INVESTMENTS FOR THE FUTURE 2020 has been a challenging year, but it is with both delight and pride I can look back on the year and...
2021-02-26 08:15
Change in Number of Shares in Nanologica AB
A share-based incentive program of a maximum of 483 883 options was decided by the Annual General Meeting May 31, 2018. The program expires July 1st, 2021...
2021-02-18 08:20
Nanologica Recruits SVP Sales and Senior Advisor for Chromatography
To accelerate sales of chromatography products following the successful upscaling of Nanologica’s silica towards ton scale, Dr. Dutta has been recruited...
2021-01-27 13:34
Nanologica Signs Collaboration Agreement with Zentiva for the use of NLAB Drug Delivery Platforms
The agreement gives Zentiva the right to use the NLAB drug delivery platforms for multiple drug development projects. Project specific agreements will...